[Ala1,3,11,15]-Endothelin 1

Ala1,3,11,15-Endothelin 1 is a synthetic peptide analog of the naturally occurring vasoactive peptide endothelin-1, in which alanine residues have been strategically substituted at positions 1, 3, 11, and 15. As a modified peptide, it is designed to probe the structure-activity relationships and functional mechanisms of endothelin signaling pathways. The analog's unique sequence alterations allow researchers to dissect the roles of specific amino acids in receptor binding, biological activity, and peptide stability. Its biochemical relevance lies in its utility for investigating the pharmacological properties of endothelin receptors and for advancing the understanding of peptide-receptor interactions within vascular biology and related fields.

Receptor Binding Studies: Researchers employ this modified endothelin-1 analog to investigate the molecular determinants of ligand-receptor interactions within the endothelin receptor family. By substituting key residues with alanine, the peptide facilitates the mapping of contact points critical for high-affinity binding to endothelin A and B receptors. These studies provide insight into the contribution of individual side chains to receptor selectivity and affinity, supporting the rational design of novel ligands or antagonists targeting these pathways.

Peptide Structure-Activity Relationship Analysis: The analog serves as a valuable tool for elucidating structure-activity relationships (SAR) in peptide hormone research. Systematic alanine scanning, as exemplified by Ala1,3,11,15-Endothelin 1, enables the assessment of how specific residue modifications impact biological activity, stability, and conformational dynamics. Such SAR investigations are essential for understanding the molecular basis of peptide function and for guiding the development of optimized analogs with tailored pharmacological profiles.

Vascular Biology and Signal Transduction Research: In studies of vascular physiology and pathophysiology, this peptide variant is utilized to dissect the signaling mechanisms mediated by endothelin receptors. By comparing the functional responses elicited by the analog versus native endothelin-1, researchers can determine the importance of specific residues in activating intracellular signaling cascades, such as calcium mobilization or kinase activation. These experiments advance the knowledge of peptide-mediated vascular regulation and endothelial cell function.

Peptide Synthesis and Analytical Method Development: The compound is also employed as a reference standard and model substrate in the optimization of solid-phase peptide synthesis protocols and analytical techniques. Its defined sequence and known modifications make it suitable for validating chromatographic methods, mass spectrometric analysis, and peptide purification strategies. This supports the development of robust methodologies for producing and characterizing complex peptide analogs in research and industrial settings.

Pharmacological Profiling and Antagonist Screening: The analog is instrumental in the pharmacological profiling of small molecules or biologics designed to modulate endothelin receptor activity. By serving as a test ligand in competitive binding assays or functional screens, it enables the identification and characterization of novel receptor antagonists or modulators. These applications are critical for advancing drug discovery efforts targeting endothelin-mediated signaling pathways implicated in cardiovascular and other physiological processes.

1. Sex differences in oxidative stress level and antioxidative enzymes expression and activity in obese pre-diabetic elderly rats treated with metformin or liraglutide

2. SERS spectrum of the peptide thymosin‐β4 obtained with Ag nanorod substrate

3. Cationic cell-penetrating peptides are potent furin inhibitors

4. High fat diet and GLP-1 drugs induce pancreatic injury in mice

5. Novel Peptide-Based PD1 Immunomodulators Demonstrate Efficacy in Infectious Disease Vaccines and Therapeutics